2,655
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 184-190 | Received 19 Nov 2019, Accepted 03 Feb 2020, Published online: 24 Feb 2020

References

  • Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;52(3):1800328. doi:10.1183/13993003.00328-2018.
  • Crimi C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46–52. doi:10.1097/ACI.0000000000000492.
  • Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465–1475. [https://doi.org/26251586]
  • Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11(6):605–614. doi:10.3109/15412555.2014.922174.
  • Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Cataluna JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. doi:10.1164/rccm.201208-1518OC.
  • Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400–407. doi:10.1164/rccm.200305-648OC.
  • Goeminne PC, Nawrot TS, Ruttens D, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 2014;108(2):287–296. doi:10.1016/j.rmed.2013.12.015.
  • Hill AT, Haworth CS, Aliberti S, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6):1700051. doi:10.1183/13993003.00051-2017.
  • Kawamatawong T, Onnipa J, Suwatanapongched T. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. COPD. 2018;13:761–769. doi:10.2147/COPD.S139776.
  • Helviz Y, Einav S. A systematic review of the high-flow nasal cannula for adult patients. Crit Care. 2018;22(1):71. doi:10.1186/s13054-018-1990-4.
  • Cortegiani A, Crimi C, Sanfilippo F, et al. High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care. 2019;50:250–256. doi:10.1016/j.jcrc.2018.12.015.
  • Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019;25(6):348–354. doi:10.1016/j.pulmoe.2019.08.001.
  • Spoletini G, Cortegiani A, Gregoretti C. Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: a narrative review. Trends in Anaesthesia and Critical Care. 2019; 26-27:22–29. doi:10.1016/j.tacc.2019.02.001.
  • Cortegiani A, Accurso G, Mercadante S, et al. High flow nasal therapy in perioperative medicine: from operating room to general ward. BMC Anesthesiol. 2018;18(1):166. doi:10.1186/s12871-018-0623-4.
  • Kilgour E, Rankin N, Ryan S, et al. Mucociliary function deteriorates in the clinical range of inspired air temperature and humidity. Intensive Care Med. 2004;30(7):1491–1494. doi:10.1007/s00134-004-2235-3.
  • Hasani A, Chapman TH, McCool D, et al. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008;5(2):81–86. doi:10.1177/1479972307087190.
  • Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104(4):525–533. doi:10.1016/j.rmed.2009.12.016.
  • Braunlich J, Kohler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077–1085.
  • Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis. 2018;10(2):882–888. doi:10.21037/jtd.2018.01.125.
  • Fraser JF, Spooner AJ, Dunster KR, et al. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016;71(8):759–761. doi:10.1136/thoraxjnl-2015-207962.
  • Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. Eur Respir J. 2015;45(2):310–313. doi:10.1183/09031936.00170014.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2018 report; 2018.
  • Naidich DP, McCauley DI, Khouri NF, et al. Computed tomography of bronchiectasis. J Comput Assist Tomogr. 1982;6(3):437–444. doi:10.1097/00004728-198206000-00001.
  • Kohnlein T, Windisch W, Kohler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705. doi:10.1016/S2213-2600(14)70153-5.
  • Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc. 1994;26(9):1078–1081.
  • Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62(10):989–993.
  • Boucher RC. Muco-Obstructive Lung Diseases. N Engl J Med. 2019;380(20):1941–1953. doi:10.1056/NEJMra1813799.
  • Panchabhai TS, Mukhopadhyay S, Sehgal S, et al. Plugs of the air passages: a clinicopathologic review. Chest. 2016;150(5):1141–1157. doi:10.1016/j.chest.2016.07.003.
  • Spoletini G, Alotaibi M, Blasi F, et al. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest. 2015;148(1):253–261. doi:10.1378/chest.14-2871.
  • Williams R, Rankin N, Smith T, et al. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med. 1996;24(11):1920–1929. doi:10.1097/00003246-199611000-00025.
  • Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology. 2017;22(6):1149–1155. doi:10.1111/resp.13050.
  • Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J. 2018;12(6):2046–2056. doi:10.1111/crj.12772.
  • Garrido D, Assioun JJ, Keshishyan A, et al. Respiratory rate variability as a prognostic factor in hospitalized patients transferred to the intensive care unit. Cureus. 2018;10(1):e2100.10.7759/cureus.2100. doi:10.7759/cureus.2100.
  • Mundel T, Feng S, Tatkov S, et al. Mechanisms of nasal high flow on ventilation during wakefulness and sleep. J Appl Physiol.2013;114(8):1058–1065. doi:10.1152/japplphysiol.01308.2012.
  • Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–1215. doi:10.1164/rccm.201605-0916OC.
  • Gregoretti C, Pisani L, Cortegiani A, et al. Noninvasive ventilation in critically ill patients. Crit Care Clin. 2015;31(3):435–457. doi:10.1016/j.ccc.2015.03.002.
  • Carlucci A, Schreiber A, Mattei A, et al. The configuration of bi-level ventilator circuits may affect compensation for non-intentional leaks during volume-targeted ventilation. Intensive Care Med. 2013;39(1):59–65. doi:10.1007/s00134-012-2696-8.
  • Cortegiani A, Crimi C, Noto A, et al. Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate. Crit Care. 2019;23(1):201. doi:10.1186/s13054-019-2473-y.
  • Mistraletti G, Pelosi P, Mantovani ES, et al. Delirium: clinical approach and prevention. Best Pract Res Clin Anaesthesiol. 2012;26(3):311–326. doi:10.1016/j.bpa.2012.07.001.
  • Pirret AM, Takerei SF, Matheson CL, et al. Nasal high flow oxygen therapy in the ward setting: a prospective observational study. Intensive Crit Care Nurs. 2017;42:127–134. doi:10.1016/j.iccn.2017.04.001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.